Restricted
Fungicidal therapy of yeast or mold infection.
Invasive candidiasis, aspergillosis, cryptococcosis.
Visceral/mucocutaneous Leishmaniasis.
Induction therapy for dimorphic fungii (cocci, blasto, histo).
Frequency depends on course, but daily reasonable during initiation.
Same toxicities as conventional Amphotericin B but with less frequency.
Infusion-related symptoms
Electrolyte abnormalities
Main concern is concomitant nephrotoxins. Use should be minimized during amphotericin therapy.
Antimicrobial class: Antifungal. Polyene. Lipid formulations designed to minimize toxicity.
Pregnancy Category: B (per conventional form)
Average serum half life: 7-10 hours, can be prolonged with very long durations of therapy
Urine penetration: Poor
Lung penetration: Therapeutic
Biliary penetration: Therapeutic